» Articles » PMID: 15820797

Efficacy of in Vitro Fertilization After Chemotherapy

Overview
Journal Fertil Steril
Date 2005 Apr 12
PMID 15820797
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate if in vitro fertilization (IVF) with embryo cryopreservation can be proposed to patients immediately after one or two regimens of chemotherapy.

Design: Retrospective study.

Setting: Academic research center and IVF unit.

Patient(s): Eleven young patients diagnosed with cancer between September 1999 and April 2003 who wanted to preserve their fertility via IVF.

Intervention(s): Stimulation and IVF before or soon after chemotherapy treatment.

Main Outcome Measure(s): The number and quality of embryos obtained after stimulation in cancer patients undergoing IVF before or soon after chemotherapeutic treatment.

Result(s): Four patients underwent IVF in the interval between two regimens of chemotherapy. Two of them had no follicular development; one underwent follicular puncture but no oocytes were retrieved; and, in one, six oocytes were harvested but only one good quality embryo was obtained. In the seven patients who underwent IVF before starting chemotherapy, between 4 and 11 embryos were obtained per patient, the majority being good quality embryos.

Conclusion(s): Because the efficacy of IVF is dramatically reduced after even one round of chemotherapy, IVF should be performed before chemotherapy. For those who require immediate chemotherapy, ovarian tissue cryopreservation and/or oocyte cryopreservation could be used before treatment.

Citing Articles

Molecular Mechanisms Determining Mammalian Oocyte Quality with the Treatment of Cancer Therapy.

Dong R, Abazarikia A, Luan Y, Yu S, Kim S Adv Anat Embryol Cell Biol. 2024; 238:97-119.

PMID: 39030356 DOI: 10.1007/978-3-031-55163-5_5.


Fertility preservation before and after cancer treatment in children, adolescents, and young adults.

Yang E, Strohl H, Su H Cancer. 2023; 130(3):344-355.

PMID: 37962199 PMC: 10841998. DOI: 10.1002/cncr.35108.


Assisted reproductive technology use and outcomes in childhood cancer survivors.

Keefe K, Lanes A, Stratton K, Green D, Chow E, Oeffinger K Cancer. 2023; 130(1):128-139.

PMID: 37732943 PMC: 10841316. DOI: 10.1002/cncr.34995.


Minimal Infiltrative Disease Identification in Cryopreserved Ovarian Tissue of Girls with Cancer for Future Use: A Systematic Review.

Grubliauskaite M, van der Perk M, Bos A, Meijer A, Gudleviciene Z, van den Heuvel-Eibrink M Cancers (Basel). 2023; 15(17).

PMID: 37686475 PMC: 10486797. DOI: 10.3390/cancers15174199.


Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases.

Saito S, Yamada M, Yano R, Takahashi K, Ebara A, Sakanaka H J Ovarian Res. 2023; 16(1):159.

PMID: 37563616 PMC: 10416401. DOI: 10.1186/s13048-023-01250-x.